This inventor holds 1 USPTO granted patent. Top assignee: H. Lundbeck A/s. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ethan W Ojala: Innovator in Antibody Development
Introduction
Ethan W Ojala is a notable inventor recognized for his contributions to the field of biotechnology. He has made significant strides in the development of humanized antibodies, which have important applications in medical research and treatment.
Latest Patents
Ethan holds a patent titled "Nucleic Acids Encoding Humanized Anti-Pacap Antibodies." This patent reflects his innovative approach to creating antibodies that can target specific biological pathways, potentially leading to advancements in therapeutic interventions.
Career Highlights
Ethan is currently employed at H. Lundbeck A/S, a company known for its focus on brain diseases and innovative treatments. His work at Lundbeck has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Ethan has worked alongside talented colleagues, including Maria-Cristina Loomis and Leon F Garcia-Martinez. These collaborations have fostered a dynamic research environment, enhancing the development of new therapeutic solutions.
Conclusion
Ethan W Ojala's contributions to the field of biotechnology, particularly in antibody development, highlight his role as an innovator. His work continues to pave the way for advancements in medical treatments and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile